Does resting heart rate predict survival in patients with advanced colorectal, pancreatic, and non-small cell lung cancer?
Resting heart rate is an independent predictor of mortality in advanced cancer patients and may represent a novel therapeutic target.
The present study is the first to show that resting heart rate independently of haemoglobin and tumour stage predicts survival in patients with advanced colorectal, pancreatic, and non-small cell lung cancer, and may therefore represent a therapeutic target.
Anker et al. (Thu,) studied this question.